Enzymes show off new moves
Enzymes are responsible for the chemical reactions that enable all forms of life. Whether it’s the archaea living in hot springs, the bacteria deep in our soil, the plants harnessing energy from the sun or all animals, including us humans, we are all united in our reliance on enzymes.
Understanding enzymatic chemistry enables us to tackle critical health and environmental problems, such as designing new therapeutics for diseases or using unique enzymatic capabilities for bioremediation. However, we have only skimmed the surface of learning the full scope of chemical reactions that are enzymatically catalyzed, the mysterious and intricate mechanisms that can be performed, and the dynamic motions enzymes undergo to accomplish their chemical tasks.
The presentations in this session will cover many exciting developments in enzymology, including recently discovered enzymatic functions, evidence for trapping long-anticipated enzymatic intermediates, insight into how various cofactors can enable unique reactions, and cutting-edge experimental approaches enabling us to understand better how enzymes dynamically function. There’s still a whole lot to learn about how enzymes get their jobs done.
Keywords: enzymes, enzyme mechanisms, structural biology, biochemistry, radical SAM enzymes, metalloenzymes, natural product biosynthesis
Who should attend: all who are fascinated by how enzymes can use some newly discovered tricks, handy cofactors and dynamic movements to carry out their chemistry
Theme song: “This is How We Do It” by Montell Jordan
This session is powered proteins, cofactors and coffee.
Talks
- Repairing enzymes using spare parts — Cathy Drennan, Howard Hughes Medical Institute and Massachusetts Institute of Technology
- Machinery in motion: New insights into mitochondrial proteostasis — Gabriel Lander, Scripps Research
- Structural biology of natural product biosynthetic enzymes — Janet Smith, University of Michigan
- An aerobic strategy for C–H bond functionalization — Jennifer Bridwell–Rabb, University of Michigan
- Riboflavin catabolism: The destruction of an icon — Tadhg Begley, Texas A&M University
- Correlated motions in enzymes — Nozomi Ando, Cornell University
- Nickel pincer nucleotide: Biosynthesis and function — Robert Hausinger, Michigan State University
- Bacterial biosynthesis of natural products —Katherine Ryan, University of British Columbia
- Radical SAMs and the vast unexplored chemistry of RiPP natural products —Douglas Alan Mitchell, University of Illinois Urbana–Champaign
- The biosynthesis of lipoic acid: A saga of death, destruction and rebirth — Squire Booker, Penn State University
- Unraveling the secrets of radical SAM mechanisms — Joan Broderick, Montana State University
- How do aerobic organisms solve the oxygen sensitivity problem of [4Fe–4S] in radical SAM enzymes? — Hening Lin, Howard Hughes Medical Institute and Cornell University
Learn more
Check out all ten thematic symposia planned for the 2022 ASBMB annual meeting:
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreFeatured jobs
from the ASBMB career center
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles
Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.
How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent MCP paper.
A game changer in cancer kinase target profiling
A new phosphonate-tagging method improves kinase inhibitor profiling, revealing off-target effects and paving the way for safer, more precise cancer therapies tailored to individual patients. Read more about this recent MCP paper.
How scientists identified a new neuromuscular disease
NIH researchers discover Morimoto–Ryu–Malicdan syndrome, after finding shared symptoms and RFC4 gene variants in nine patients, offering hope for faster diagnosis and future treatments.
Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.
How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.